Press Release PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit THE ROSEN LAW FIRM, P. A. · Jul 29
Press Release Martinrea International Inc. to Announce Second Quarter Results on August 4, 2026 Martinrea International Inc. · Jul 29
Press Release Rosen Law Firm Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation – ENSG THE ROSEN LAW FIRM, P. A. · Jul 29
Press Release Kuehn Law Encourages Investors of Five9, Inc. to Contact Law Firm KUEHN LAW, PLLC · Jul 29
Press Release Hopstem Receives U.S. FDA IND Clearance and Fast Track designations for hNPC01 in Hemorrhagic Stroke and Traumatic Brain Injury-Expanding Clinical Development Across Three Major Brain Injury Indications Hopstem Biotechnology Inc. · Jul 29
Press Release Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm KUEHN LAW, PLLC · Jul 29
Press Release Chris Vrame Debunks 5 Myths About Real Estate Development and Big Projects Issuewire · Jul 29
Press Release Travere Therapeutics to Report Second Quarter 2026 Financial Results Business Wire · Jul 29
Press Release Imagen Network Advances AI Content Infrastructure for Creator Networks Issuewire · Jul 29
Press Release On to Release Second Quarter 2026 Results on Tuesday, August 11, 2026 Business Wire · Jul 29
Press Release AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata AbbVie · Jul 29
Press Release Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Following Whistleblower Lawsuit Of Financial Manipulation Business Wire · Jul 29
Press Release AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo AbbVie · Jul 29